NFL BIOSCIENCES (EPA:ALNFL)

REGULATED PRESS RELEASE

published on 12/05/2024 at 08:02, 16 days 11 hours ago

NFL BIOSCIENCES VALIDATES THE INDUSTRIALIZATION OF NFL-101 FOR SMOKING CESSATION
REGULATED PRESS RELEASE

published on 12/05/2024 at 08:02, 16 days 11 hours ago

NFL BIOSCIENCES VALIDE L’INDUSTRIALISATION DE NFL-101 POUR LE SEVRAGE TABAGIQUE
BRIEF

published on 11/18/2024 at 17:50, 1 month 3 days ago

NFL Biosciences Presents NFL-101 at Tobacco Congress

NFL Biosciences Smoking Cessation NFL-101 Tobaccology Disruptive Mechanism
BRIEF

published on 11/18/2024 at 17:50, 1 month 3 days ago

NFL Biosciences présente NFL-101 au congrès de tabacologie

NFL Biosciences NFL-101 Sevrage Tabagique Tabacologie Mécanisme Disruptif
REGULATED PRESS RELEASE

published on 11/18/2024 at 17:45, 1 month 3 days ago

NFL BIOSCIENCES : LE MÉCANISME D’ACTION NOUVEAU ET DISRUPTIF DE NFL-101 POUR LE SEVRAGE TABAGIQUE PRÉSENTÉ AU CONGRÈS ANNUEL DE LA SOCIÉTÉ FRANCOPHONE DE TABACOLOGIE
Restrictions on publication in the US, UK, Canada, Australia, and Japan

Canada UK Publication US Restrictions
REGULATED PRESS RELEASE

published on 10/18/2024 at 08:00, 2 months 3 days ago

NFL BIOSCIENCES : L’ÉQUIPE DIRIGEANTE PRÉPARE LES PROCHAINES ÉTAPES DU DÉVELOPPEMENT
REGULATED PRESS RELEASE

published on 10/18/2024 at 08:00, 2 months 3 days ago

NFL BIOSCIENCES: LEADERSHIP TEAM PREPARING THE NEXT STAGES IN ITS DEVELOPMENT
REGULATED PRESS RELEASE

published on 10/08/2024 at 08:00, 2 months 13 days ago

NFL BIOSCIENCES: EFFICACY VALIDATED THROUGH UPDATED ANALYSES FROM CESTO II FOR SMOKING CESSATION. SIGNIFICANT REDUCTION IN CRAVING. STRONG COMMERCIAL POTENTIAL CONFIRMED.
REGULATED PRESS RELEASE

published on 10/08/2024 at 08:00, 2 months 13 days ago

NFL BIOSCIENCES : VALIDATION DE L’EFFICACITÉ PAR DES ANALYSES ACTUALISÉES DE CESTO II EN SEVRAGE TABAGIQUE. RÉDUCTION SIGNIFICATIVE DU CRAVING. FORT POTENTIEL COMMERCIAL CONFIRMÉ.
BRIEF

published on 09/27/2024 at 17:50, 2 months 24 days ago

NFL Biosciences : Activités et résultats du 1er semestre 2024

Résultats Financiers NFL Biosciences NFL-101 Sevrage Tabagique Candidat Médicament

1 2 ... 7

Published on 12/21/2024 at 01:30, 17 hours 35 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 35 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours 5 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 35 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 18 hours 13 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 19 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 23 hours 54 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 6 hours 47 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 6 hours 47 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News